Metraipolis › archive › dc_e974ae57acfa

Overcoming resistance to immune checkpoint inhibitor in non-small cell lung cancer: the promise of combination therapy — Europe PMC PMID:41268560

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41268560
DOI
10.3389/fimmu.2025.1691980
License (as archived)
solo-consultazione
Archived
2026-11-08T18:45:38.161Z
SHA-256 of the archived text
598b1da6685e02fc4d797e33661e94dc8bc634c431781ac1c272accda587f6e7
Stable URL of this page
https://metraipolis.com/documento/dc_e974ae57acfa

How to cite

Overcoming resistance to immune checkpoint inhibitor in non-small cell lung cancer: the promise of combination therapy — Europe PMC PMID:41268560 — Europe PMC (en), https://europepmc.org/article/MED/41268560 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e974ae57acfa (Metraipolis archive dc_e974ae57acfa, sha256 598b1da6685e02fc4d797e33661e94dc8bc634c431781ac1c272accda587f6e7)
BibTeX
@misc{dce974ae57acfa,
  title = {Overcoming resistance to immune checkpoint inhibitor in non-small cell lung cancer: the promise of combination therapy — Europe PMC PMID:41268560},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41268560},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e974ae57acfa; sha256 598b1da6685e02fc4d797e33661e94dc8bc634c431781ac1c272accda587f6e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41268560. Agents can read the archived copy with the MCP tool read_document.